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Abstract
Background: Thoracic surgery mandates usually a one-lung ventilation (OLV) strategy with the collapse of the
operated lung and ventilation of the non-operated lung. These procedures trigger a substantial inflammatory
response. The aim of this study was to analyze the cytokine and chemokine reaction in both lungs, pleural space
and blood in patients undergoing lung resection with OLV with special interest in the chemokine growth-
regulated peptide alpha (GROa) which is the human equivalent to the rat cytokine-induced neutrophil
chemoattractant-1 (CINC-1).
Methods: Broncho-alveolar lavage (BAL) fluid of both the collapsed, operated and the ventilated, non-operated
lung, respectively, pleural space drainage fluid and blood was collected and the concentrations of interleukin (IL)-6,
IL-1RA and GROa were determined with enzyme-linked immunosorbent assays in 15 patients.
Results: Substantial inter-individual differences in the BAL fluid between patients in cytokine and chemokine levels
occurred. In the pleural fluid and the blood these inter-individual differences were less pronounced. Both sides of the
lung were affected and showed a significant increase in IL-6 and IL-1RA concentrations over time but not in GROa
concentrations. Except for IL-6, which increased more in the collapsed, operated lung, no difference between the
collapsed, operated and the ventilated, non-operated lung occurred. In the blood, IL-6 and IL-1RA increased early,
already at the end of surgery. GROa was not detectable. In the pleural fluid, both cytokine and chemokine
concentrations increased by day one. The increase was significantly higher in the pleural fluid compared to the blood.
Conclusion: The inflammatory response of cytokines affects both the collapsed, operated and the ventilated, non-
operated lungs. The difference in extent of response underlines the complexity of the inflammatory processes during
OLV. In contrast to the cytokines, the chemokine GROa concentrations did not react in the BAL fluid or in the blood.
This indicates that GROa might not be useful as marker for the inflammatory reaction in complex surgical procedures.
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Background
Thoracic surgery such as esophagectomy or lobectomy
triggers a more severe systemic inflammatory reaction than
intra-abdominal surgery [1]. One possible explanation is
the fact that most thoracic procedures mandate a one-lung
ventilation (OLV) strategy. The OLV leads to a collapse of
the lung that is operated with subsequent shunting of
blood and possible hypoxemia. The contralateral lung is
ventilated and may suffer from ventilator-induced injury,
hyperoxia and increased capillary stress [2-4].
A number of studies investigated cytokine levels in thor-
acic surgery [5-9]. The degree of inflammatory response
depended on the extent of the surgical trauma (thoracot-
omy vs. video-assisted thoracic surgery) and the nature of
the disease (benign vs. malign) [5-7]. Cytokine levels, espe-
cially interleukin-6 (IL-6) and interleukin-8 (IL-8), were
associated with postoperative infections and systemic
inflammatory response syndrome, which itself was a
predictive factor the duration of the hospital stay [8,9].
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still unclear. Most studies addressing cytokine production
in thoracic surgery measured serum cytokine levels. Mea-
surements in other compartments such as the pleural
space and the collapsed and ventilated lungs by bronchoal-
veolar lavage (BAL) are scarce. Cree et al. demonstrated
higher IL-8 levels in the BAL fluid after esophagectomy
compared to the peripheral blood [10]. These authors also
analyzed BAL samples from both lungs without showing a
difference. However, the authors compared right and left
lungs of two different groups of patients. Our group
demonstrated a more pronounced inflammatory response
on the ventilated left lung in patients undergoing trans-
thoracic esophagectomy [11]. As cytokine concentrations
vary substantially between patients, it is important to ana-
lyze both lungs of the same patient.
A variety of chemokines have recently been shown to
play an important role in inflammation. One is the rat
cytokine-induced neutrophil chemoattractant-1 (CINC-1).
CINC-1 is an acute phase protein with the ability to
recruit neutrophils [12]. The human equivalent to the rat
CINC-1 is the growth-regulated peptide alpha GROa.T o
our knowledge, the role of GROa as human equivalent to
CINC-1 in the inflammatory reaction in patients under-
going thoracic surgery has not been studied so far.
Thus, the aim of this study was to analyze the inflamma-
tory response represented by the pro-inflammatory cyto-
kine IL-6, the anti-inflammatory cytokine interleukin-1
receptor antagonist (IL-1RA) and the chemokine GROa
in the operated, collapsed and the non-operated, ventilated
lungs, in the pleural space and the peripheral blood in
patients undergoing lobectomy for cancer with special
interest in the reaction of the chemokine GROa.W e
hypothesized that the pro-inflammatory GROa shows a
similar reaction to the pro-inflammatory cytokine IL-6.
Patients and methods
From the 1
st of June 2007 all patients undergoing thora-
cotomy and resection for non-small cell lung cancer at the
University Hospital Basel, Switzerland, were assessed for
eligibility to be included in this prospective observational
study. Exclusion criteria were pneumonectomy, minimal
invasive procedures and refusal of the patient to partici-
pate. The Ethics committee of the state of Basel has
approved the study. Informed consent was obtained from
all patients.
Anesthetic procedure and surgery
Anesthetic procedures were standardized for all patients
including the use of double-lumen endobronchial tubes
under fiber-optic control to allow single lung ventilation.
All patients received a thoracic epidural catheter with
continuous infusion of local anesthetics both intraopera-
tively (ropivacaine 0.3%) and postoperatively
(bupivacaine 0.125%). Total intravenous anesthesia was
applied using bolus doses of fentanyl and continuous
infusions of propofol and remifentanil intraoperatively
and tempered until endotracheal extubation. Muscle
relaxation (intraoperatively only) was achieved using
bolus doses of rocuronium. One-lung ventilation during
thoracotomy followed the principles of a lung protective
strategy, using pressure-limited or pressure-controlled
ventilation modes with tidal volumes of <7 ml/kg body
weight, positive end-expiratory pressure of 3-5 cm H2O
and limiting peak inspiratory pressures to <30 cm H2O.
Inspired oxygen concentration on the ventilated lung
was set to 100% at the beginning and gradually reduced
thereafter based on the arterial oxygen tension measured
by repeated blood gas analyses [13-15]. Continuous
monitoring included ECG analysis, measurement of
arterial oxygen saturation with pulse oxymetry and inva-
sive arterial as well as central venous pressure monitor-
ing. Blood samples were drawn intermittently at
predefined time points for blood gas and further labora-
tory parameter analysis.
Surgery was performed by two consultant thoracic
surgeons with the following surgical technique: after
performing a lateral thoracotomy with entering the
pleural cavity either through the fourth or the fifth
intercostal space the lobe with the tumor was mobilized
by preparation of the hilum and the interlobar fissures.
During this procedure a part of the systematic mediast-
inal lymph node dissection according to the American
Thoracic Society mapping was performed [16]. Then the
tumor was resected either by a lobectomy, a bilobect-
omy, a sleeve-lobectomy or by an anatomical segmen-
tectomy using staplers for the vascular, bronchial and
parenchymal resection. After completing the systematic
lymph node dissection the operation was finished by
positioning one or two chest tubes.
BAL, pleural lavage and peripheral blood samples
Bilateral BAL was performed in all patients in supine
position after intubation and at the completion of sur-
gery. The bronchoscope was wedged in the lower
bronchus of both lungs and a lavage with 50ml of sterile
saline was performed. The BAL fluid was immediately
centrifuged at 2500rpm for 15 minutes and the superna-
tant stored at -20°C.
Lavage of the pleural space was performed after thora-
cotomy and before closure of the thoracotomy with
100ml of sterile saline. On day 1-3, pleural fluid samples
were taken in a standardized way. The tubes were
clamped close to the chest and the collection system.
Then the pleural fluid was aspirated from the tube using
a standard 20 gauge needle. All samples were taken by
the same investigator. The fluid was processed as
described above for the BAL samples.
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same time as the BAL and pleural fluid samples on the
day of surgery and on day 1-3. Again, the samples were
processed as described.
Cytokine assays
The concentrations of IL-6, IL-1RA and GROa in the
BAL, pleural space and blood samples were determined
with enzyme-linked immune-sorbent assays (ELISA, R &
D Systems, Minneapolis, MN, USA). To standardize the
BAL fluid samples for optimal comparison, we extrapo-
lated the results retrieved in the ELISA to a sample
volume of 10ml.
Statistical analysis
Comparison of data between the groups was undertaken
using Chi-square tests for categorical data, and Wilcoxon
signed rank tests for continuous data. Data is presented as
mean values with standard deviation (SD) or median
values with inter-quartile range (IQR) as appropriate.
Based on a paired t-test with a type 1 error set at 0.05 the
sample size of 15 patients allowed an 82% power to detect
a size effect difference of 0.8. Statistical significance was
set at p < 0.05. Statistical analyses were performed with
Medcalc
®, Version 9 for Windows.
Results
Patients, pathology and morbidity
There were 7 men and 8 women in the study cohort. The
mean age was 65 years (SD 13 years) and mean body mass
index was 24.9 kg/m
2 (SD 5.8 kg/m
2). Preoperative pul-
monary function tests showed a mean forced expiratory
volume (FEV1) of 2.3 liters (SD 0.9 liters) and a vital capa-
city (VC) of 3.3 liters (SD 1.1 liters). The mean FEV1/VC
percentage was 71.0% (SD 14.1.0%). Mean cardiac ejection
fraction determined by preoperative echocardiography was
56.5% (SD 7.0%).
Chronic obstructive pulmonary disease was present in
three patients (20%), five patients had cardiac comorbid-
ities (33%, two with atrial fibrillation, three with coronary
heart disease), and five patients (33%) had pre-existing
renal impairment. Table 1 summarizes the surgical, anes-
thetic and the pathological data. There were no deaths
and no surgical morbidity. The only postoperative morbid-
ity was two patients with pneumonia.
BAL fluid cytokine assay
The BAL cytokine and chemokine measurements showed
substantial inter-individual differences in both the operated,
collapsed and non-operated, ventilated lung for all media-
tors as demonstrated for IL-6 as example in Figures 1, 2
and 3. The results of the BAL measurements are demon-
strated in table 2. Except for IL-6, no differences between
the operated, collapsed and non-operated, ventilated lung
occurred. Over time (at intubation vs. end of surgery) the
pro-inflammatory IL-6 and the anti-inflammatory IL-1RA
showed a significant increase in the operated, collapsed
lung (IL-6 p < 0.001, IL-1RA p < 0.001), whereas in the
non-operated, ventilated lung only IL-6 significantly
increased (p = 0.006) but not IL-1RA (p = 0.525). GROa
showed no significant change over time (operated, col-
lapsed lung p = 0.720, non-operated, ventilated lung
p = 0.978).
Blood and pleural fluid cytokine assays
The pleural fluid and blood cytokine assays demon-
strated less inter-individual differences as shown for
IL-6 in Figure 4. IL-1RA demonstrated a similar inter-
individual pattern whereas GROa did not. Table 3
shows the results of the pleural and blood cytokine and
chemokine assays. The cytokines reacted significantly
more pronounced in the pleural fluid compared to the
blood, starting with a certain delay on the first post-
operative day.
The pro-inflammatory IL-6 significantly increased
early in the blood, already at the end of surgery, thus
only a few hours after the surgical trauma (at intubation
4 pg/ml, at end of surgery 38 pg/ml; p = 0.001). From
the end of surgery to day one, the concentrations
increased further, however, not reaching statistical sig-
nificance (at end of surgery 38 pg/ml, day one 99 pg/ml;
p = 0.153). Although the anti-inflammatory IL-1RA also
increased, this increase was not significant. GROa was
not detectable in the blood.
In the pleural fluid, IL-6 levels increased on day one,
but not at the end of surgery (at intubation 14 pg/ml, at
the end of surgery 417 pg/ml; p = 0.168; day one 27309
pg/ml; p < 0.001). IL-1RA levels were significantly
higher at the end of surgery compared to the baseline at
the intubation, and increased more significantly on day
Table 1 Surgical and pathological data
SURGICAL PROCEDURES
LOBECTOMY 11
BI-LOBECTOMY 1
SEGMENTECTOMY 1
SLEEVE LOBECTOMY 2
MEAN LENGTH OF OPERATION IN MINUTES (SD) 190 (59)
MEAN LENGTH OF ANAESTHETIC PROCEDURE IN MINUTES
(SD)
402 (91)
MEAN LENGTH OF ONE LUNG VENTILATION IN MINUTES (SD) 156 (73)
MEAN BLOOD LOSS IN MILILITRES (SD) 420
(156)
TYPE OF TUMOR
LARGE CELL CARCINOMA 3
ADENOCARCINOMA 9
SQUAMOUS CELL CANCER 3
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pg/ml; p = 0.034; day one 20277 pg/ml; p < 0.001).
GROa showed a similar pattern as IL-1RA (at intuba-
tion 17 pg/ml, at the end of surgery 50 pg/ml; p =
0.007; day one 258 pg/ml; p < 0.001).
Discussion
The main finding of this study is the fact that the chemo-
kine GROa did not react similarly to the cytokines IL-6
and IL-1RA in the BAL and the blood. All patients showed
a significant increase of the bronchoalveolar cytokines in
both the operated, collapsed and non-operated, ventilated
lungs. Analyzing BAL fluid from both lungs of the same
patient is important to avoid bias due to the substantial
variation in cytokine levels in the individual patient
[10,17]. Our results support this finding as the inter-indivi-
dual difference in both the operated, collapsed and the
non-operated, ventilated lung, respectively, was substantial
for all three mediators. To our knowledge, no study has
analyzed the inflammatory response in both lungs of the
same patient in open lung surgery. In most patients the
increase of IL-6 levels in the BAL fluid was moderate, but
in some patients the IL-6 levels were very high, explaining
the differences between the median and mean values. In
contrast, in the pleural fluid and the blood the inter-
patient variability was less pronounced for IL-6 and
IL-1RA, and no variability occurred for GROa.S o m e
patients had a more pronounced reaction compared with
the majority, both in the pleural fluid and in the blood.
The reason for this remains unclear, as we did not detect
any difference in the frequency of inflammatory complica-
tions between these patients. A number of studies
reported an inter-subject variability of various inflamma-
tory markers, but again the exact reasons remain unclear
[18,19]. Aaron et al. analyzed sputum and serum speci-
mens from patients with stable chronic obstructive
Figure 1 Course of IL-6 in the operated collapsed and non-operated ventilated lungs in the individual 15 patients.
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Page 4 of 10Figure 2 Course of IL-1RA in the operated collapsed and non-operated ventilated lungs in the individual 15 patients.
Figure 3 Course of CINC-1 in the operated collapsed and non-operated ventilated lungs in the individual 15 patients.
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Page 5 of 10Table 2 Comparison of the median and mean cytokine levels in the BAL fluid of the right and left lung
BAL COLLAPSED
OPERATED LUNG
RATIO OF CYTOKINE RESPONSE
COLLAPSED OPERATED LUNG*
BAL VENTILATED
NON-OPERATED
LUNG
RATIO OF CYTOKINE RESPONSE
VENTILATED NON-OPERATED LUNG*
P VALUE#
BAL OPERATED COLLAPSED LUNG COMPARED
TO BAL NON-OPERATED VENTILATED LUNG
IL-6 (PG/ML),
MEDIAN/MEAN
(IQR)
AT
INTUBATION
63/236 (4-271) 13.5 118/222 (12-148) 5.2 1.000
END OF
SURGERY
1486/3176 (452-
5681)
710/1159 (99-1899) 0.010
IL-1RA (PG/ML),
MEDIAN/MEAN
(IQR)
AT
INTUBATION
7144/15289 (3316-
17921)
2.3 7144/19863 (3469-
29394)
2.9 0.670
END OF
SURGERY
14837/35242 (9803-
56578)
12878/57543 (5943-
35014)
0.252
GROa (PG/ML),
MEDIAN/MEAN
(IQR)
AT
INTUBATION
13467/30597 (6967-
26499)
0.6 10137/18043 (5132-
24379)
1.0 0.720
END OF
SURGERY
15133/19187 (7330-
22047)
11252/18552 (3487-
20038)
0.599
*Concentration at intubation as base line for calculation of ratio
# Wilcoxon paired samples test
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0pulmonary disease and controls, and found similar results
to our study, i.e. a more substantial reaction in the speci-
men sampled directly from the lungs [19]. These authors
explained their finding with the higher variability in day-
to-day amount and dilution of analyzed sputum, however,
after correction of their results by normalizing for the spu-
tum total protein some of the variability remained.
The pro-inflammatory IL-6 reacted more on the oper-
ated, collapsed lung and showed in median a 13-time
higher concentration in the BAL fluid at the end of sur-
gery. The anti-inflammatory IL-1RA reacted in both
lungs similarly, with a two- to three-fold increase. This is
in contrast to a recent analysis of our group in patients
who underwent transthoracic esophagectomy with OLV,
where a more pronounced reaction on the ventilated side
was observed [11]. One possible explanation for this dif-
ference is the fact that in lung surgery the tissue damage
is created directly on the lung, thus triggering a more
severe reaction on the operated side that is subsequently
measured in the BAL fluid. In contrast, in esophagec-
tomies the inflammatory response is likely to be triggered
by the OLV itself through high oxygen concentrations
and the direct mechanical stress on the alveolar walls
[20].
GROa showed no increase in the BAL fluid. GROa is
the human equivalent to the rat CINC-1 that is an acute
phase protein and induces recruitment of neutrophils,
thus is a pro-inflammatory mediator. We hypothesized
that GROa levels would increase similar to the pro-
inflammatory cytokines, in both lungs. Only limited data
on chemokines after surgical procedures exist. Seitz et
al. showed that chemokine levels in BAL fluid of rats
subjected to blunt chest trauma increased compared to
sham [21]. Schilling et al. demonstrated an increase of
intra-alveolar granulocytes in the ventilated lung in
patients undergoing thoracic surgery with OLV [22]. In
their study, the increase in cells occurred two hours
postoperatively. One reason for the lack in increase of
Figure 4 Course of IL-6 in the pleural fluid and blood plasma in the individual 15 patients.
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Page 7 of 10Table 3 Comparison of the median and mean cytokine levels in the pleura fluid with the levels in the peripheral blood
PLEURAL FLUID RATIO OF CYTOKINE RESPONSE
PLEURAL FLUID*
PERIPHERAL
BLOOD
RATIO OF CYTOKINE RESPONSE
PERIPHERAL BLOOD*
P VALUE#
PLEURAL FLUID VERSUS
BLOOD
IL-6 (PG/ML), MEDIAN/MEAN
(IQR)
AT THORACOTOMY/
INTUBATION
0/14 (0-21) 29.8 0/4 (0-10) 9.5 0.109
END OF SURGERY 58/417 (22-396) 1950.6 16/38 (7-41) 24.8 0.085
DAY 1 23448/27309 (12900-
34929)
1889.9 54/99 (39-84) 10.5 <0.001
DAY 2 11396/26458 (6510-
18582)
914.3 28/42 (16-31) 11.0 <0.001
DAY 3 4709/12800 (3590-
19392)
13/44 (2-24) <0.001
IL-1RA (PG/ML), MEDIAN/
MEAN (IQR)
AT THORACOTOMY/
INTUBATION
9/46 (0-76) 5.8 75/470 (0-979) 1.2 0.102
END OF SURGERY 140/267 (11-252) 440.8 134/580 (0-913) 1.6 0.525
DAY 1 16239/20277 (10210-
23527)
335.5 516/735 (0-1251) 1.1 <0.001
DAY 2 8062/15435 (3477-
15589)
261.3 112/492 (4-949) 1.1 <0.001
DAY 3 4364/12018 (3152-
13764)
147/524 (0-1184 <0.001
GROa (PG/ML), MEDIAN/
MEAN (IQR)
AT THORACOTOMY/
INTUBATION
3/17 (0-30) 2.9 0/183 (0-257) 1.1 0.193
END OF SURGERY 25/50 (7-57) 15.2 0/201 (0-224) 0.7 0.525
DAY 1 172/258 (118-306) 11.2 0/136 (0-282) 0.6 0.017
DAY 2 64/190 (25-179) 7.4 0/114 (0-145) 0.6 0.268
DAY 3 97/125 (29-182) 0/105 (0-116) 0.389
The pleural samples were taken immediately after the thoracotomy and before closure of the thoracotomy. On day 1-3 the pleural and peripheral blood samples were taken at the same time.
*Concentration at intubation as base line for calculation of ratio (means used for calculation)
# Wilcoxon paired samples test
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the chemokine in the lung. In our study, GROa levels
peaked in the pleural fluid on day one whereas no sub-
stantial increase was seen at the end of surgery. This
m i g h ti n d i c a t eas l o w e ri n c r e a s eo v e rt i m e .T h er o l eo f
the various chemokines in inflammation is not clear,
however, their potential role in targeting and blocking
inflammatory processes has been recognized in hepatic
diseases, rheumatoid arthritis or allergic asthma [23,24].
In the peripheral blood, the pro-inflammatory IL-6 levels
increased substantially and peaked on day one. The anti-
inflammatory IL-1RA showed also an increase, but less
pronounced. Similar findings have been described in
most major surgical procedures. However, transthoracic
procedures seem to trigger a more pronounced pro-inflam-
matory reaction [1]. The main reason seems to be the thor-
acotomy. Yim et al. demonstrated lower IL-6 levels in
video-assisted thoracic surgery (VATS) compared to open
thoracic surgery [5]. For both, IL-6 and IL-1RA, the
increase in the peripheral blood occurred already at the end
of surgery, thus early in the time course and only shortly
after the surgical trauma occurred. Also, both cytokines
showed significantly higher levels in the locally sampled
fluids, i.e. BAL and pleural fluid. The inflammatory reaction
seems to be generated primarily locally. Also, depression of
cytokine production in the peripheral blood might contri-
bute to this less pronounced increase [25]. Considering the
high postoperative morbidity of these operations, the early
postoperative IL-6 levels could be of interest for early
detection of infectious complications. IL-6 has been
detected as early marker for postoperative sepsis [26]. In
our study, no analysis stratified according postoperative
morbidity was possible due to a low number of patients
and a very low postoperative complication rate.
Similar to the levels in the BAL fluid, we were not able
to detect an increase in the GROa levels in the blood. On
postoperative day one, the GROa level in the blood was
even decreased. We were not able to explain this finding.
Our results indicate that the usefulness of GROa levels in
the peripheral blood as markers of inflammation may be
limited.
In the pleural fluid, IL-6, IL-1RA and GROa increased.
Similar to the blood, the peak occurred on day one, but
the increase was already detectable at the end of the sur-
gery. The levels in the pleural fluid were significantly
higher compared to the blood. This finding is consistent
to other reports measuring pleural fluid cytokine levels in
patients undergoing esophagectomy [27,28]. Overall, data
on the inflammatory reaction in the pleural space is scarce.
Weissflog et al. demonstrated higher pleural concentra-
tions of IL-10 and other cytokines in non-malignant
diseases, and in patients undergoing VATS [29]. Szczesny
et al. showed substantially higher levels of IL-6 and
IL-1RA in the pleural fluid compared to the serum [30].
The elevation of cytokines persists to day three, which
may also be influenced by the thoracic drains. The pleural
cavity seems to be an important location of inflammation.
GROa levels were only elevated in this compartment.
GROa is a potent chemoattractant for neutrophils, and
this influx of cells might also influence the tumor-immu-
nological environment. The production of oxygen radicals
by neutrophils might decrease the ability of anti-tumor
acting cells, such as natural killer cells, to eliminate free
tumor cells.
The main limitation of this study is the number of
patients, and thus, our results mandate careful interpre-
tation. However, with our sample size of 15 patients we
w e r ep o w e r e du pt od e t e c tam a j o rd i f f e r e n c eb e t w e e n
operated and non-operated lungs.
Performing BAL on both lungs of each patients is
complex, time consuming and not without risk. The
results presented in this study are, to our knowledge,
the first demonstrating the time course of chemokines
in lung surgery and give a first insight in the cytokine
and chemokine reaction in complex thoracic surgery.
Further studies to determine the impact of the loco-
regional inflammatory response and its clinical relevance
after thoracic surgery are necessary.
Conclusion
The inflammatory response of pro- and anti-inflamma-
tory cytokines affects both the collapsed operated and the
ventilated contralateral lungs. The inter-individual differ-
ence was present in the BAL of the lungs but less in the
pleural space and in the blood, respectively. The differ-
ence in extent of response underlines the complexity of
the inflammatory processes that arise during OLV in
thoracic surgery. Loco-regional inflammatory reactions
were more pronounced compared to the blood. The
inflammatory response occurred shortly after the surgical
trauma, thus indicating that measurements must be done
timely. GROa increased in the pleural fluid but neither
in the BAL fluid nor in the blood and might not be useful
as marker for systemic inflammatory response in com-
plex surgery.
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